Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K
Cesca Therapeutics reports 2022 executive compensation
By ExecPay News
Published: October 26, 2023
Cesca Therapeutics reported fiscal year 2022 executive compensation information on October 26, 2023.
In 2022, three executives at Cesca Therapeutics received on average a compensation package of $526K, a 4% decrease compared to previous year.
Chris Xu, Chief Executive Officer, received $699K in total, which decreased by 7% compared to 2021. 74% of Xu's compensation, or $519K, was in salary. Xu also received $180K in bonus.
Haihong Zhu, Chief Operating Officer, received a compensation package of $554K. 83% of the compensation package, or $458K, was in salary.
Jeffery Cauble, Chief Financial Officer, earned $325K in 2022, a 7% decrease compared to previous year.